Why Risk Mitigation Tools Are A Hard Sell In Pharma—And What Might Change That Tech September 25, 2026 George Achilleos is the CEO of NetraMark Holdings Inc.Drug development has a strange economic problem.A pharmaceutical company may be willing…
